View in EDS HTML Full Text

Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: a systematic review and meta-analysis.
Authors: Smit Y; Department of Hematology, Radboud university medical center, Route 476, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. yolba.smit@radboudumc.nl., Scheuter P; Department of Hematology, Radboud university medical center, Route 476, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Lange MPM; Department of Hematology, Radboud university medical center, Route 476, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Janssen JJWM; Department of Hematology, Radboud university medical center, Route 476, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands., Bekker CL; Department of Pharmacy, Radboud university medical center, Nijmegen, The Netherlands., Hermens RPMG; Department of IQ Health, Radboud university medical center, Nijmegen, The Netherlands., Blijlevens NMA; Department of Hematology, Radboud university medical center, Route 476, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2025 May 03; Vol. 33 (5), pp. 446. Date of Electronic Publication: 2025 May 03.
Publication Type: Journal Article; Systematic Review; Meta-Analysis
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1433-7339
DOI:10.1007/s00520-025-09451-4